Treatment options for locally recurrent vulvar cancer
Authors:
Ndukwe M. 1; Práznovec I. 1; Štěpán M. 1; Sirák I. 2; Fibír A. 3; Špaček J. 1
Authors place of work:
Porodnická a gynekologická klinika LF UK a FN Hradec Králové
1; Klinika onkologie a radioterapie LF UK a FN Hradec Králové
2; Chirurgická klinika LF UK a FN Hradec Králové
3
Published in the journal:
Ceska Gynekol 2021; 86(4): 246-248
Category:
Case Report
doi:
https://doi.org/10.48095/cccg2021246
Summary
Objective: Summarizing of treatment options for locally recurrent vulvar cancer in patients after previous complex oncological treatment and presenting a case report from our department. Methods: Presenting a case report of a patient after previous complex oncological treatment for spinocellular cancer of the vulva who presented with a locally recurrent tumor. The patient was treated with a wide radical local excision of the tumor followed by a posterior thigh flap graft. Conclusion: Surgical intervention is the primary mode of treatment in locally recurrent cancers of the vulva. Wide radical local excision as a mode of treatment can be optimized by the use of grafts aiding in wound healing.
Keywords:
recurrent vulvar cancer – wide radical local excision – graft transplant – brachytherapy – Chemotherapy – Chemoradiotherapy
Zdroje
1. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet 2012; 119 (Suppl 2): S90–S96. doi: 10.1016/S0020-7292 (12) 60021-6.
2. Maggino T, Landoni F, Sartori E et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer 2000; 89 (1): 116–122. doi: 10.1002/1097-0142 (20000701) 89: 1<116:: aid-cncr16>3.0.co; 2-4.
3. De Hullu JA, Hollema H, Lolkema S et al. Vulvar carcinoma. The price of less radical surgery. Cancer 2002; 95 (11): 2331–2338. doi: 10.1002/cncr.10969.
4. Piura B, Masotina A, Murdoch J et al. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993; 48 (2): 189–195. doi: 10.1006/gyno.1993.1032.
5. Rouzier R, Haddad B, Plantier F et al. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 2002; 100 (6): 1159–1167. doi: 10.1016/s0029-7844 (02) 02501-2.
6. Woolderink JM, de Bock GH, de Hullu JA et al. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol 2006; 103 (1): 293–299. doi: 10.1016/j.ygyno.2006.03.010.
7. Heaps JM, Fu YS, Montz FJ et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990; 38 (3): 309–314. doi: 10.1016/0090-8258 (90) 90064-r.
8. Tilmans AS, Sutton GP, Look KY et al. Recurrent squamous carcinoma of the vulva. Am J Obstet Gynecol 1992; 167 (5): 1383–1389. doi: 10.1016/s0002-9378 (11) 91722-0.
9. Hopkins MP, Morley GW. Pelvic exenteration for the treatment of vulvar cancer. Cancer. 1992; 70 (12): 2835–2838. doi: 10.1002/1097-0142 (199212 15) 70: 12<2835:: aid-cncr2820701219>3.0.co; 2-u.
10. Miller B, Morris M, Levenback C et al. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 1995; 58 (2): 202–205. doi: 10.1006/gyno.1995.1211.
11. Lee PK, Choi MS, Ahn ST et al. Gluteal fold V-Y advancement flap for vulvar and vaginal reconstruction: a new flap. Plast Reconstr Surg 2006; 118 (2): 401–406. doi: 10.1097/01.prs.0000227683.47836.28.
12. Weikel W, Hofmann M, Steiner E et al. Reconstructive surgery following resection of primary vulvar cancers. Gynecol Oncol 2005; 99 (1): 92–100. doi: 10.1016/j.ygyno.2005.05.031.
13. Gentileschi S, Servillo M, Garganese G et al. Surgical therapy of vulvar cancer: how to choose the correct reconstruction? J Gynecol Oncol 2016; 27 (6): e60. doi: 10.3802/jgo.2016.27.e60.
14. Tan BK, Kang GC, Tay EH et al. Subunit principle of vulvar reconstruction: algorithm and outcomes. Arch Plast Surg 2014; 41 (4): 379–386. doi: 10.5999/aps.2014.41.4.379.
15. Pirtoli L, Rottoli M. Results of radiation therapy for vulvar carcinoma. Acta Radiol Oncol 1982; 21 (1): 45–48. doi: 10.3109/02841868209133983.
16. Faul CM, Mirmow D, Huang Q et al. Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 1997; 38 (2): 381–389. doi: 10.1016/s0360-3016 (97) 82 500-x.
17. Buchler DA, Kline JC, Tunca JC et al. Treatment of recurrent carcinoma of the vulva. Gynecol Oncol 1979; 8 (2): 180–184. doi: 10.1016/0090-8258 (79) 90023-4.
18. Kellas-Ślęczka S, Białas B, Fijałkowski M et al. Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer. J Contemp Brachytherapy 2016; 8 (1): 32–40. doi: 10.5114/jcb.2016.58081.
19. Cormio G, Loizzi V, Gissi F et al. Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma. Oncology 2009; 77 (5): 281–284. doi: 10.1159/000259259.
20. Singareddy R, Bajwa HK, Alluri KR et al. Carcinoma vulva patterns of recurrence and treatment outcomes: a single-institution experience. J Cancer Res Ther 2019; 15 (6): 1328–1331. doi: 10.4103/jcrt.JCRT_44_18.
Štítky
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineČlánok vyšiel v časopise
Czech Gynaecology
2021 Číslo 4
Najčítanejšie v tomto čísle
- Pelvic neuropathic pain (differential diagnosis)
- HELLP syndrome and HELLP-like syndrome in pregnancies with covid-19 – case reports
- Molecular testing in endometrial carcinoma – joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists
- Recurrence of rare malignant Brenner ovarian tumor